Skip to main content
    G

    Guardian Pharmacy Services, Inc. (GRDN)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $50.31
    +0.88 (+1.78%)

    Market Cap: $3.13B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Guardian Pharmacy Services, Inc. (GRDN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Guardian Pharmacy Services (GRDN) has a market cap of $3.13B and an enterprise value of $3.01B. Its trailing P/E is 41.9x.

    Total Valuation

    Enterprise value is 3.82% below the market cap, as cash exceeds debt.

    Market Cap$3.13B
    Enterprise Value$3.01B
    Latest price (Nov 17, 2026)$50.31

    Key Dates

    The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 9, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.03% in the quarter ended Sep 30, 2026.

    Shares Outstanding63.34M
    Shares Change (YoY)+1.96%
    Shares Change (QoQ)+0.03%

    Valuation Ratios

    Sales and book value multiples are 2.2x and 11.9x.

    P/E Ratio41.9x
    Forward P/E39.3x
    P/S Ratio2.2x
    Forward P/S2.2x
    P/B Ratio11.9x
    P/TBV Ratio19.4x
    P/FCF Ratio34.9x
    P/OCF Ratio27.5x
    PEG Ratio1.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 23.7x EBITDA and 33.6x free cash flow.

    EV / Earnings39.6x
    EV / Sales2.1x
    EV / EBITDA23.7x
    EV / EBIT28.5x
    EV / FCF33.6x

    Price Statistics

    The stock is up 72.24% over 52 weeks and trades 17.55% above its 50-day average.

    Beta (1Y)0.65
    52-Week Change+72.24%
    1-Month Change+25.34%
    3-Month Change+32.50%
    6-Month Change+38.67%
    Total Return (1Y)+72.24%
    Return vs SPY (1Y)+68.70%
    Max Drawdown (1Y)-18.79%
    Max Drawdown (3Y)-27.21%
    Sharpe Ratio (1Y)1.40
    Correlation with SPY (1Y)0.21
    50-Day Average$42.80
    200-Day Average$39.04
    52-Week Range$26.34 to $50.59
    RSI (14 Days)72.2
    Average Volume (20 Days)490.91K

    Price chart

    Financial Position

    Current assets cover 1.65x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.65x
    Quick Ratio1.33x
    Debt / Equity0.00x
    Interest Coverage163.29x

    Returns and Efficiency

    Return on equity is 28.46% over the last 12 months, against a 5-year average of 51.76%.

    Return on Equity (ROE)28.46%
    Return on Assets (ROA)15.46%
    Return on Capital Employed (ROCE)33.84%
    ROE (5Y Average)51.76%
    ROA (5Y Average)4.88%
    Asset Turnover3.30x
    Inventory Turnover21.02x
    Receivables Turnover13.78x
    Cash Conversion Cycle6 days

    Taxes

    Income tax took 27.68% of pretax income over the last 12 months.

    Income Tax (TTM)$29.11M
    Effective Tax Rate27.68%

    Scores

    GRDN has an Altman Z-Score of 13.31, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score13.31
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.46B over the last 12 months is up 4.85% from the 12 months before.

    Revenue$1.46B
    Revenue Growth (YoY)+4.85%
    Gross Profit$327.08M
    Operating Income$94.14M
    Pretax Income$105.16M
    Net Income$76.05M
    EBITDA$129.27M
    EBIT$105.81M
    Reported EPS (TTM)$1.20

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 54.34% of the $491.78M in total assets.

    Cash and Equivalents$119.66M
    Total Debt$0
    Net Cash$119.66M
    Net Cash Per Share$1.89
    Working Capital$115.73M
    Shareholder Equity$267.24M
    Book Value Per Share$4.22
    Tangible Book Value$164.44M
    Tangible Book Per Share$2.60
    Total Assets$491.78M
    Total Liabilities$212.06M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $22.79M of capital spending, operating cash flow left $91.27M of free cash flow.

    Operating Cash Flow$114.06M
    Capital Expenditures$22.79M
    Free Cash Flow$91.27M
    FCF Per Share$1.44
    Depreciation and Amortization$23.46M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 6.46%, against a 5-year average of 2.67%.

    Gross Margin22.45%
    Operating Margin6.46%
    Pretax Margin7.22%
    Net Margin5.22%
    EBITDA Margin8.87%
    EBIT Margin7.26%
    FCF Margin6.26%
    Gross Margin (5Y Average)20.16%
    Operating Margin (5Y Average)2.67%
    Net Margin (5Y Average)1.43%

    Growth

    Revenue grew 16.81% a year over 3 years.

    Revenue Growth (3Y CAGR)+16.81%
    Revenue Growth (5Y CAGR)+14.50%
    FCF Growth (3Y CAGR)+28.45%
    FCF Growth (5Y CAGR)+8.74%
    Operating Income Growth (3Y CAGR)+11.83%
    Book Value Per Share Growth (2Y CAGR)+164.12%

    Revenue and profit by year

    Dividends and Yields

    GRDN does not pay a dividend. Its free cash flow yield is 2.86%.

    Earnings Yield2.39%
    FCF Yield2.86%
    Buyback Yield-0.05%
    Shareholder Yield0.02%

    Peer Position

    Against 11 similar companies, GRDN has the 3rd highest P/E.

    P/E Ratio41.9x vs 24.6x median
    P/S Ratio2.2x vs 1.2x median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.85% vs +14.34% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GRDN

    What is GRDN's market cap?

    Guardian Pharmacy Services has a market cap of $3.13B. Its enterprise value, which adds debt and subtracts cash, is $3.01B.

    What is GRDN's P/E ratio?

    Guardian Pharmacy Services has a trailing P/E ratio of 41.9x and a forward P/E of 39.3x.

    How many shares of GRDN are outstanding?

    Guardian Pharmacy Services has 63.34M shares outstanding. The count is up 1.96% from a year earlier.

    Does GRDN pay a dividend?

    No. Guardian Pharmacy Services does not pay a dividend.

    How much debt does GRDN have?

    Guardian Pharmacy Services has $0 of total debt and $119.66M of cash and equivalents, a net cash position of $119.66M.